Celebrity Dresses
 
Leather Handbags
 
Hot Sale !

 
By Neckline
 
Latest News

The 2010 Emmy Awards are going on right now live from coast to coast, hosted by Jimmy Fallon, and here are all the nominees … read more

Google Inc … read more

Yes, Internet Exporer 6 was amazing … read more

 
Reviews
Wedding Dresses Wedding Dresses
text_stars
The dress arrived today. She wont be able to see it or try it on until tomorrow.
strapless, hand-beaded, a-line gown strapless, hand-beaded, a-line gown
text_stars
I recieved it yesterday and it is amazing. It is stuning, beutiful and the bead
Strapless Bridal Gown Strapless Bridal Gown
text_stars
I ordered a custom made wedding gown, based off of a designers dress. I was a li
Beaded,Satin,Tulle maids Beaded,Satin,Tulle maids
text_stars
Hi David I would like to say a big THANKYOU to you and your staff for fixing our
 
Google Adsense
 
Advertise
Free Coin Purse with purchase!

 
Trused Partner

 
Coupon

 
Need help ?
Sales Support Help
 
Shopping Cart
0 items
 
Currency
 

 
Social Media
 
Testimonals

 
Showcase
Bridal Gown
Bridal Gown
WD100155
US$230.00
 
Trusted Supplier

 
Poll
What is Your Favorite Gown Style?
Vote
View Poll Results
 
Google Adsense
 
Advertise
FreeShipping_120x60_072106

 
Trusted Site
 

Google News

Google News

Google Inc. is starting a version of its business software tailored to government customers.

The government-friendly edition of a product called Google Apps will focus on local, state and federal agencies, Google said at a news conference Monday.

The Mountain View company unveiled the version after receiving certification from the U.S Federal Information Security Management Act, which applies to all systems the federal government uses. The new certification gives government and commercial customers more confidence in Google's applications, said David Girouard, president of the enterprise business.

biotech
Genentech's experimental medicine
Roche Holding AG's Genentech unit has agreed to buy rights to an experimental medicine being developed by Nov-Immune SA, a closely held Swiss biotechnology company.

The early stage compound, a so-called anti-IL-17 fully human monoclonal antibody, may be developed to treat inflammatory and autoimmune diseases, NovImmune said Monday. The company didn't provide financial details of the deal.

These bioengineered molecules mimic the action of the body's own response to infections.

NovImmune expects Genentech, in South San Francisco, to begin testing the compound in people next year.

Onyx drug aids some patients
Onyx Pharmaceuticals Inc. said its experimental drug helped about a quarter of patients with advanced blood cancer whose illness hadn't been halted by other treatments.

Onyx stock gained 21 percent Monday, the most in a year, after announcing results of the trial on carfilzomib. The study found 24 percent of patients with multiple myeloma had at least a partial response, and their improvement lasted a median of 7.4 months, the Emeryville company said in a statement. The research followed 266 patients, Onyx said.

Multiple myeloma causes uncontrolled growth of blood plasma cells and can lead to bone tumors that hinder the body's ability to make infection-fighting cells.

energy
Chevron eyes Down Under
Chevron Corp. expects its Wheatstone gas project in Australia to gain environmental approval in the first quarter of 2011, allowing it to start construction in the second half of next year.

The liquefied natural gas venture may have as many as six processing units and produce as much as 25 million metric tons of the fuel a year, Chevron Australia said in an environmental review filed on its website.

The Wheatstone and Gorgon projects, among more than a dozen proposed LNG ventures in Australia targeting an increase in Asian demand for cleaner-burning fuel, are centerpieces of Chevron's global growth plans, the company says on its site.

patents
Rambus wins Nvidia fight
Rambus Inc. of Los Altos won its patent-infringement fight against Nvidia Corp. over imports of computer-graphics chips.

Nvidia, in Santa Clara, violated Rambus' patent rights, the U.S. International Trade Commission in Washington said in a decision on its website Monday. 

original news from below links:-

http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2010/07/26/BUC71EK1JH.DTL